Viral dynamics in mild and severe cases of COVID-19 - PubMed (original) (raw)

Viral dynamics in mild and severe cases of COVID-19

Yang Liu et al. Lancet Infect Dis. 2020 Jun.

No abstract available

PubMed Disclaimer

Figures

Figure

Viral dynamics in patients with mild and severe COVID-19 (A) DCT values (Ctsample-Ctref) from patients with mild and severe COVID-19 at different stages of disease onset. Median, quartile 1, and quartile 3 are shown. (B) DCT values of serial samples from patients with mild and severe COVID-19. COVID-19=coronavirus disease 2019. *p<0·005.

Similar articles

• 63 days detection of SARS-CoV-2 RNA from a recovered patient in Southern Italy: A Case Report.
  Baldacci S, Giannico OV, Giorgino A, Buccoliero GB, Desiante F, Fragnelli GR, Rizzi R, Loconsole D, Centrone F, Chironna M, Conversano M. Baldacci S, et al. Ann Ig. 2020 Sep-Oct;32(5):590-592. doi: 10.7416/ai.2020.2378. Ann Ig. 2020. PMID: 32744589 No abstract available.
• Clinical features of discharged COVID-19 patients with an extended SARS-CoV-2 RNA positive signal in respiratory samples.
  Li J, Wei X, Tian W, Zou J, Wang Y, Xue W, Xiao Q, Huang W. Li J, et al. Virus Res. 2020 Sep;286:198047. doi: 10.1016/j.virusres.2020.198047. Epub 2020 Jun 6. Virus Res. 2020. PMID: 32522535 Free PMC article.
• Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2.
  Li W, Su YY, Zhi SS, Huang J, Zhuang CL, Bai WZ, Wan Y, Meng XR, Zhang L, Zhou YB, Luo YY, Ge SX, Chen YK, Ma Y. Li W, et al. Clin Microbiol Infect. 2020 Nov;26(11):1556.e1-1556.e6. doi: 10.1016/j.cmi.2020.07.008. Epub 2020 Jul 9. Clin Microbiol Infect. 2020. PMID: 32653662 Free PMC article.
• BET 2: Hydroxychloroquine in the treatment of COVID-19.
  Howard L, Baombe J, Reynard C. Howard L, et al. Emerg Med J. 2020 Jul;37(7):451-453. doi: 10.1136/emermed-2020-210221.3. Emerg Med J. 2020. PMID: 32616659 Review. No abstract available.
• Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China.
  Awadasseid A, Wu Y, Tanaka Y, Zhang W. Awadasseid A, et al. Int J Biol Sci. 2020 Apr 6;16(11):1846-1860. doi: 10.7150/ijbs.45018. eCollection 2020. Int J Biol Sci. 2020. PMID: 32398954 Free PMC article. Review.

Cited by

• Trends in SARS-CoV-2 Cycle Threshold Values in Bosnia and Herzegovina-A Retrospective Study.
  Moro A, Softić A, Travar M, Goletić Š, Omeragić J, Koro-Spahić A, Kapo N, Mrdjen V, Terzić I, Ostojic M, Cerkez G, Goletic T. Moro A, et al. Microorganisms. 2024 Aug 4;12(8):1585. doi: 10.3390/microorganisms12081585. Microorganisms. 2024. PMID: 39203427 Free PMC article.
• Cycle threshold (Ct)values of SARS-CoV2 vary with the type of symptoms and comorbidities of the patients.
  Shoaib N, Munir R. Shoaib N, et al. Mol Biol Rep. 2024 Jul 25;51(1):851. doi: 10.1007/s11033-024-09804-y. Mol Biol Rep. 2024. PMID: 39052089
• Clinical Significance of Quantitative Viral Load in Patients Positive for SARS-CoV-2.
  Finks SW, Van Matre E, Budd W, Lemley E, Ray NK, Mahon M, Chambers E, Finks AL. Finks SW, et al. Am J Med Open. 2023 Jul 11;10:100050. doi: 10.1016/j.ajmo.2023.100050. eCollection 2023 Dec. Am J Med Open. 2023. PMID: 39035250 Free PMC article.
• A robust web-based tool to predict viral shedding in patients with Omicron SARS-CoV-2 variants.
  Zhang W, Gai X, Wang B, Duan Z, Zhou Q, Dai L, Yan C, Wu C, Fan J, Wang P, Yang P, Bao F, Jing H, Cai C, Song C, Ma Y, Sun Y. Zhang W, et al. ERJ Open Res. 2024 May 20;10(3):00939-2023. doi: 10.1183/23120541.00939-2023. eCollection 2024 May. ERJ Open Res. 2024. PMID: 38779041 Free PMC article.
• Epidemiological and health economic implications of symptom propagation in respiratory pathogens: A mathematical modelling investigation.
  Asplin P, Keeling MJ, Mancy R, Hill EM. Asplin P, et al. PLoS Comput Biol. 2024 May 3;20(5):e1012096. doi: 10.1371/journal.pcbi.1012096. eCollection 2024 May. PLoS Comput Biol. 2024. PMID: 38701066 Free PMC article.

References

1. 1. Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30113-4. published online Feb 24. - DOI - PMC - PubMed
2. 1. Zou L, Ruan F, Huang M. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020 doi: 10.1056/NEJMc2001737. published online Jan 30. - DOI - PMC - PubMed
3. 1. Guan WJ, Ni ZY, Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 doi: 10.1056/NEJMoa2002032. published online Feb 28. - DOI - PMC - PubMed
4. 1. Yang X, Yu Y, Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020 doi: 10.1016/S2213-2600(20)30079-5. published online Feb 24. - DOI - PMC - PubMed
5. 1. WHO Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. 2020. https://www.who.int/publications-detail/laboratory-testing-for-2019-nove...

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations